RxDoctor Payments Data

Sadie Johnson, PA

Physician Assistant · Holdrege, NENPI 1942623541

Payments from drug & device makers

$1,245in general payments, 2019–2025

Across 71 payments — averaging $17.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$435
  • Boston Scientific$178
  • Johnson & Johnson$156
  • Amgen$103
  • Merck$70
  • Medtronic$58
  • plus $246 from 8 others

What the payments were for

  • Consulting fees$272%
  • Food & beverage$1,20497%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,245 in reported general payments places this provider in the 70th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$4,276
Medicare patients
37
Services billed
63

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban54$28,562
XareltoRivaroxaban28$17,180
EntrestoSacubitril/Valsartan28$12,667
JardianceEmpagliflozin21$12,353
Repatha SureclickEvolocumab11$5,834
Ranolazine ErRanolazine84$2,590
Metoprolol Succinate266$2,073
Flecainide Acetate43$1,708
Potassium Chloride109$1,317
Rosuvastatin Calcium233$1,054
Midodrine Hcl36$903
ClopidogrelClopidogrel Bisulfate98$571
Amiodarone Hcl82$563
Isosorbide Mononitrate ErIsosorbide Mononitrate98$497
Losartan Potassium149$491

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$156$17,18028 claims
NovartisEntresto$435$12,66728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Holdrege

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →